These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugs. Feske S Cell Calcium; 2019 Jun; 80():112-116. PubMed ID: 31009822 [TBL] [Abstract][Full Text] [Related]
9. Functional analyses of STIM1 mutations reveal a common pathomechanism for tubular aggregate myopathy and Stormorken syndrome. Peche GA; Spiegelhalter C; Silva-Rojas R; Laporte J; Böhm J Neuropathology; 2020 Dec; 40(6):559-569. PubMed ID: 33073872 [TBL] [Abstract][Full Text] [Related]
10. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis. Nesin V; Wiley G; Kousi M; Ong EC; Lehmann T; Nicholl DJ; Suri M; Shahrizaila N; Katsanis N; Gaffney PM; Wierenga KJ; Tsiokas L Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4197-202. PubMed ID: 24591628 [TBL] [Abstract][Full Text] [Related]
11. Interplay between ER Ca Nelson HA; Leech CA; Kopp RF; Roe MW Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783744 [TBL] [Abstract][Full Text] [Related]
12. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome. Böhm J; Laporte J Cell Calcium; 2018 Dec; 76():1-9. PubMed ID: 30243034 [TBL] [Abstract][Full Text] [Related]
13. The TAM-associated STIM1 Kim JH; Carreras-Sureda A; Didier M; Henry C; Frieden M; Demaurex N Cell Calcium; 2022 Jul; 105():102615. PubMed ID: 35792400 [TBL] [Abstract][Full Text] [Related]
14. ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain. Bulla M; Gyimesi G; Kim JH; Bhardwaj R; Hediger MA; Frieden M; Demaurex N J Physiol; 2019 Jan; 597(2):561-582. PubMed ID: 30382595 [TBL] [Abstract][Full Text] [Related]
15. Silencing of the Ca Silva-Rojas R; Pérez-Guàrdia L; Lafabrie E; Moulaert D; Laporte J; Böhm J Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805973 [TBL] [Abstract][Full Text] [Related]
16. A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy. Cordero-Sanchez C; Riva B; Reano S; Clemente N; Zaggia I; Ruffinatti FA; Potenzieri A; Pirali T; Raffa S; Sangaletti S; Colombo MP; Bertoni A; Garibaldi M; Filigheddu N; Genazzani AA Dis Model Mech; 2019 Dec; 13(2):. PubMed ID: 31666234 [TBL] [Abstract][Full Text] [Related]
17. Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1. Böhm J; Chevessier F; Koch C; Peche GA; Mora M; Morandi L; Pasanisi B; Moroni I; Tasca G; Fattori F; Ricci E; Pénisson-Besnier I; Nadaj-Pakleza A; Fardeau M; Joshi PR; Deschauer M; Romero NB; Eymard B; Laporte J J Med Genet; 2014 Dec; 51(12):824-33. PubMed ID: 25326555 [TBL] [Abstract][Full Text] [Related]
18. 50 years to diagnosis: Autosomal dominant tubular aggregate myopathy caused by a novel STIM1 mutation. Walter MC; Rossius M; Zitzelsberger M; Vorgerd M; Müller-Felber W; Ertl-Wagner B; Zhang Y; Brinkmeier H; Senderek J; Schoser B Neuromuscul Disord; 2015 Jul; 25(7):577-84. PubMed ID: 25953320 [TBL] [Abstract][Full Text] [Related]
19. STIM1 over-activation generates a multi-systemic phenotype affecting the skeletal muscle, spleen, eye, skin, bones and immune system in mice. Silva-Rojas R; Treves S; Jacobs H; Kessler P; Messaddeq N; Laporte J; Böhm J Hum Mol Genet; 2019 May; 28(10):1579-1593. PubMed ID: 30576443 [TBL] [Abstract][Full Text] [Related]
20. The store-operated Ca Shen Y; Thillaiappan NB; Taylor CW Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]